Point: Low-density lipoprotein cholesterol goals in patients with diabetes are not adequately based on evidence.
Department of Medicine, Division of Endocrinology, Metabolism, Lipids, 49 Jesse Hill Jr Drive, Emory University School of Medicine, Atlanta, Georgia 30303, USA. agosman@emory.edu
Aidar R
AR
Gosmanov
D002318:Cardiovascular Diseases / Q000517:prevention & control; D008078:Cholesterol, LDL / Q000097:blood*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications / Q000517:prevention & control; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy*; D019317:Evidence-Based Medicine; D005260:Female; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D008297:Male; D017410:Practice Guidelines as Topic; D012307:Risk Factors
D008078:Cholesterol, LDL; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors